1369628-59-0

Basic information

• Product Name: 1-(4-fluoro-2-hydroxy-5-methoxyphenyl)ethanone
• Synonyms: 1-(4-fluoro-2-hydroxy-5-methoxyphenyl)ethanone
• CAS NO: 1369628-59-0
• Molecular Weight: 184.167
• Mol File: 1369628-59-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-(4-fluoro-2-hydroxy-5-methoxyphenyl)ethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-fluoro-2-hydroxy-5-methoxyphenyl)ethanone(1369628-59-0)
• EPA Substance Registry System: 1-(4-fluoro-2-hydroxy-5-methoxyphenyl)ethanone(1369628-59-0)

Safety Data

• Hazardous Substances Data: 1369628-59-0(Hazardous Substances Data)

Upstream product

• 452-11-9 3-fluoro-4-methoxyphenol 
• 351-54-2 3-fluoro-p-anisaldehyde 
• 34036-07-2 3,4 difluorobenzaldehyde 
• 1493-13-6 trifluorormethanesulfonic acid 
• 946833-20-1 acetic acid 3-fluoro-4-methoxyphenyl ester 
• 455-91-4 1-(3-fluoro-4-methoxyphenyl)ethanone 

Relevant articles and documents

NOVEL NUCLEOSIDE PHOSPHORAMIDATE COMPOUND AND USE THEREOF

The present invention provides a novel nucleoside phosphoramidate compound, or a stereoisomer, salt, hydrate, solvate or crystal thereof for the treatment of Flaviviridae family viral infection, especially hepatitis C viral infection. The present invention also provides the pharmaceutical composition comprising a compound of the present invention, or a stereoisomer, salt, hydrate, solvate or crystal thereof and a use of the compound or the composition of the present invention in the treatment of Flaviviridae family viral infection, especially hepatitis C viral infection. The compound of the present invention has a good anti-HCV effect.

COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES

The invention provides novel tricyclic compounds of Formula I' that inhibit β-secretase cleavage of APP and are useful as therapeutic agents for treating neurodegenerative diseases.